United States Peptide Therapeutics Market Report 2017

Market: Pharma & Healthcare

, 0 pages report, published by QYResearch

Report ThumbnailAugust-2017
In this report, the United States Peptide Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Peptide Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Peptide Therapeutics market competition by top manufacturers/players, with Peptide Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Eli Lilly and Company
Bachem Holding
Amgen
Roche
GlaxoSmithKline
Novartis
Sanofi
Takeda Pharmaceutical Company
Teva Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
by Phase
Liquid Phase
Solid Phase
Hybrid Phase
by Type of Molecule
Vasopressin
Somatostatin
Calcitonin
Immunopeptide
Natriuretic
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Peptide Therapeutics for each application, including
Hospitals Pharmacies
Retail Pharmacies
Drug Stores
E-Commerce

If you have any special requirements, please let us know and we will offer you the report as you want.

  • List of Tables and Figures
  • Figure Product Picture of Peptide Therapeutics
  • Figure United States Peptide Therapeutics Market Size (K Units) by Type (2012-2022)
  • Figure United States Peptide Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
  • Figure Liquid Phase Product Picture
  • Figure Solid Phase Product Picture
  • Figure Hybrid Phase Product Picture
  • Figure United States Peptide Therapeutics Market Size (K Units) by Application (2012-2022)
  • Figure United States Sales Market Share of Peptide Therapeutics by Application in 2016
  • Figure Hospitals Pharmacies Examples
  • Table Key Downstream Customer in Hospitals Pharmacies
  • Figure Retail Pharmacies Examples
  • Table Key Downstream Customer in Retail Pharmacies
  • Figure Drug Stores Examples
  • Table Key Downstream Customer in Drug Stores
  • Figure E-Commerce Examples
  • Table Key Downstream Customer in E-Commerce
  • Figure United States Peptide Therapeutics Market Size (Million USD) by Region (2012-2022)
  • Figure The West Peptide Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
  • Figure Southwest Peptide Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
  • Figure The Middle Atlantic Peptide Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
  • Figure New England Peptide Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
  • Figure The South of US Peptide Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
  • Figure The Midwest Peptide Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
  • Figure United States Peptide Therapeutics Sales (K Units) and Growth Rate (2012-2022)
  • Figure United States Peptide Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
  • Figure United States Peptide Therapeutics Market Major Players Product Sales Volume (K Units) (2012-2017)
  • Table United States Peptide Therapeutics Sales (K Units) of Key Players/Suppliers (2012-2017)
  • Table United States Peptide Therapeutics Sales Share by Players/Suppliers (2012-2017)
  • Figure 2016 United States Peptide Therapeutics Sales Share by Players/Suppliers
  • Figure 2017 United States Peptide Therapeutics Sales Share by Players/Suppliers
  • Figure United States Peptide Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
  • Table United States Peptide Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
  • Table United States Peptide Therapeutics Revenue Share by Players/Suppliers (2012-2017)
  • Figure 2016 United States Peptide Therapeutics Revenue Share by Players/Suppliers
  • Figure 2017 United States Peptide Therapeutics Revenue Share by Players/Suppliers
  • Table United States Market Peptide Therapeutics Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
  • Figure United States Market Peptide Therapeutics Average Price (USD/Unit) of Key Players/Suppliers in 2016
  • Figure United States Peptide Therapeutics Market Share of Top 3 Players/Suppliers
  • Figure United States Peptide Therapeutics Market Share of Top 5 Players/Suppliers
  • Table United States Players/Suppliers Peptide Therapeutics Manufacturing Base Distribution and Sales Area
  • Table United States Players/Suppliers Peptide Therapeutics Product Category
  • Table United States Peptide Therapeutics Sales (K Units) by Region (2012-2017)
  • Table United States Peptide Therapeutics Sales Share by Region (2012-2017)
  • Figure United States Peptide Therapeutics Sales Share by Region (2012-2017)
  • Figure United States Peptide Therapeutics Sales Market Share by Region in 2016
  • Table United States Peptide Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
  • Table United States Peptide Therapeutics Revenue Share by Region (2012-2017)
  • Figure United States Peptide Therapeutics Revenue Market Share by Region (2012-2017)
  • Figure United States Peptide Therapeutics Revenue Market Share by Region in 2016
  • Table United States Peptide Therapeutics Price (USD/Unit) by Region (2012-2017)
  • Table United States Peptide Therapeutics Sales (K Units) by Type (2012-2017)
  • Table United States Peptide Therapeutics Sales Share by Type (2012-2017)
  • Figure United States Peptide Therapeutics Sales Share by Type (2012-2017)
  • Figure United States Peptide Therapeutics Sales Market Share by Type in 2016
  • Table United States Peptide Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
  • Table United States Peptide Therapeutics Revenue Share by Type (2012-2017)
  • Figure Revenue Market Share of Peptide Therapeutics by Type (2012-2017)
  • Figure Revenue Market Share of Peptide Therapeutics by Type in 2016
  • Table United States Peptide Therapeutics Price (USD/Unit) by Types (2012-2017)
  • Figure United States Peptide Therapeutics Sales Growth Rate by Type (2012-2017)
  • Table United States Peptide Therapeutics Sales (K Units) by Application (2012-2017)
  • Table United States Peptide Therapeutics Sales Market Share by Application (2012-2017)
  • Figure United States Peptide Therapeutics Sales Market Share by Application (2012-2017)
  • Figure United States Peptide Therapeutics Sales Market Share by Application in 2016
  • Table United States Peptide Therapeutics Sales Growth Rate by Application (2012-2017)
  • Figure United States Peptide Therapeutics Sales Growth Rate by Application (2012-2017)
  • Table Pfizer Basic Information List
  • Table Pfizer Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
  • Figure Pfizer Peptide Therapeutics Sales Growth Rate (2012-2017)
  • Figure Pfizer Peptide Therapeutics Sales Market Share in United States (2012-2017)
  • Figure Pfizer Peptide Therapeutics Revenue Market Share in United States (2012-2017)
  • Table Eli Lilly and Company Basic Information List
  • Table Eli Lilly and Company Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
  • Figure Eli Lilly and Company Peptide Therapeutics Sales Growth Rate (2012-2017)
  • Figure Eli Lilly and Company Peptide Therapeutics Sales Market Share in United States (2012-2017)
  • Figure Eli Lilly and Company Peptide Therapeutics Revenue Market Share in United States (2012-2017)
  • Table Bachem Holding Basic Information List
  • Table Bachem Holding Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
  • Figure Bachem Holding Peptide Therapeutics Sales Growth Rate (2012-2017)
  • Figure Bachem Holding Peptide Therapeutics Sales Market Share in United States (2012-2017)
  • Figure Bachem Holding Peptide Therapeutics Revenue Market Share in United States (2012-2017)
  • Table Amgen Basic Information List
  • Table Amgen Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
  • Figure Amgen Peptide Therapeutics Sales Growth Rate (2012-2017)
  • Figure Amgen Peptide Therapeutics Sales Market Share in United States (2012-2017)
  • Figure Amgen Peptide Therapeutics Revenue Market Share in United States (2012-2017)
  • Table Roche Basic Information List
  • Table Roche Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
  • Figure Roche Peptide Therapeutics Sales Growth Rate (2012-2017)
  • Figure Roche Peptide Therapeutics Sales Market Share in United States (2012-2017)
  • Figure Roche Peptide Therapeutics Revenue Market Share in United States (2012-2017)
  • Table GlaxoSmithKline Basic Information List
  • Table GlaxoSmithKline Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
  • Figure GlaxoSmithKline Peptide Therapeutics Sales Growth Rate (2012-2017)
  • Figure GlaxoSmithKline Peptide Therapeutics Sales Market Share in United States (2012-2017)
  • Figure GlaxoSmithKline Peptide Therapeutics Revenue Market Share in United States (2012-2017)
  • Table Novartis Basic Information List
  • Table Novartis Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
  • Figure Novartis Peptide Therapeutics Sales Growth Rate (2012-2017)
  • Figure Novartis Peptide Therapeutics Sales Market Share in United States (2012-2017)
  • Figure Novartis Peptide Therapeutics Revenue Market Share in United States (2012-2017)
  • Table Sanofi Basic Information List
  • Table Sanofi Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
  • Figure Sanofi Peptide Therapeutics Sales Growth Rate (2012-2017)
  • Figure Sanofi Peptide Therapeutics Sales Market Share in United States (2012-2017)
  • Figure Sanofi Peptide Therapeutics Revenue Market Share in United States (2012-2017)
  • Table Takeda Pharmaceutical Company Basic Information List
  • Table Takeda Pharmaceutical Company Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
  • Figure Takeda Pharmaceutical Company Peptide Therapeutics Sales Growth Rate (2012-2017)
  • Figure Takeda Pharmaceutical Company Peptide Therapeutics Sales Market Share in United States (2012-2017)
  • Figure Takeda Pharmaceutical Company Peptide Therapeutics Revenue Market Share in United States (2012-2017)
  • Table Teva Pharmaceutical Basic Information List
  • Table Teva Pharmaceutical Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
  • Figure Teva Pharmaceutical Peptide Therapeutics Sales Growth Rate (2012-2017)
  • Figure Teva Pharmaceutical Peptide Therapeutics Sales Market Share in United States (2012-2017)
  • Figure Teva Pharmaceutical Peptide Therapeutics Revenue Market Share in United States (2012-2017)
  • Table Production Base and Market Concentration Rate of Raw Material
  • Figure Price Trend of Key Raw Materials
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Peptide Therapeutics
  • Figure Manufacturing Process Analysis of Peptide Therapeutics
  • Figure Peptide Therapeutics Industrial Chain Analysis
  • Table Raw Materials Sources of Peptide Therapeutics Major Players/Suppliers in 2016
  • Table Major Buyers of Peptide Therapeutics
  • Table Distributors/Traders List
  • Figure United States Peptide Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
  • Figure United States Peptide Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
  • Figure United States Peptide Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
  • Table United States Peptide Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
  • Figure United States Peptide Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
  • Figure United States Peptide Therapeutics Sales Volume (K Units) Forecast by Type in 2022
  • Table United States Peptide Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
  • Figure United States Peptide Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
  • Figure United States Peptide Therapeutics Sales Volume (K Units) Forecast by Application in 2022
  • Table United States Peptide Therapeutics Sales Volume (K Units) Forecast by Region (2017-2022)
  • Table United States Peptide Therapeutics Sales Volume Share Forecast by Region (2017-2022)
  • Figure United States Peptide Therapeutics Sales Volume Share Forecast by Region (2017-2022)
  • Figure United States Peptide Therapeutics Sales Volume Share Forecast by Region in 2022
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
  • Table of Contents
  • United States Peptide Therapeutics Market Report 2017
  • 1 Peptide Therapeutics Overview
  • 1.1 Product Overview and Scope of Peptide Therapeutics
  • 1.2 Classification of Peptide Therapeutics by Product Category
  • 1.2.1 United States Peptide Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
  • 1.2.2 United States Peptide Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  • 1.2.3 Liquid Phase
  • 1.2.4 Solid Phase
  • 1.2.5 Hybrid Phase
  • 1.3 United States Peptide Therapeutics Market by Application/End Users
  • 1.3.1 United States Peptide Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  • 1.3.2 Hospitals Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Drug Stores
  • 1.3.5 E-Commerce
  • 1.4 United States Peptide Therapeutics Market by Region
  • 1.4.1 United States Peptide Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  • 1.4.2 The West Peptide Therapeutics Status and Prospect (2012-2022)
  • 1.4.3 Southwest Peptide Therapeutics Status and Prospect (2012-2022)
  • 1.4.4 The Middle Atlantic Peptide Therapeutics Status and Prospect (2012-2022)
  • 1.4.5 New England Peptide Therapeutics Status and Prospect (2012-2022)
  • 1.4.6 The South Peptide Therapeutics Status and Prospect (2012-2022)
  • 1.4.7 The Midwest Peptide Therapeutics Status and Prospect (2012-2022)
  • 1.5 United States Market Size (Value and Volume) of Peptide Therapeutics (2012-2022)
  • 1.5.1 United States Peptide Therapeutics Sales and Growth Rate (2012-2022)
  • 1.5.2 United States Peptide Therapeutics Revenue and Growth Rate (2012-2022)
  • 2 United States Peptide Therapeutics Market Competition by Players/Suppliers
  • 2.1 United States Peptide Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
  • 2.2 United States Peptide Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
  • 2.3 United States Peptide Therapeutics Average Price by Players/Suppliers (2012-2017)
  • 2.4 United States Peptide Therapeutics Market Competitive Situation and Trends
  • 2.4.1 United States Peptide Therapeutics Market Concentration Rate
  • 2.4.2 United States Peptide Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  • 2.4.3 Mergers & Acquisitions, Expansion in United States Market
  • 2.5 United States Players/Suppliers Peptide Therapeutics Manufacturing Base Distribution, Sales Area, Product Type
  • 3 United States Peptide Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017)
  • 3.1 United States Peptide Therapeutics Sales and Market Share by Region (2012-2017)
  • 3.2 United States Peptide Therapeutics Revenue and Market Share by Region (2012-2017)
  • 3.3 United States Peptide Therapeutics Price by Region (2012-2017)
  • 4 United States Peptide Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
  • 4.1 United States Peptide Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
  • 4.2 United States Peptide Therapeutics Revenue and Market Share by Type (2012-2017)
  • 4.3 United States Peptide Therapeutics Price by Type (2012-2017)
  • 4.4 United States Peptide Therapeutics Sales Growth Rate by Type (2012-2017)
  • 5 United States Peptide Therapeutics Sales (Volume) by Application (2012-2017)
  • 5.1 United States Peptide Therapeutics Sales and Market Share by Application (2012-2017)
  • 5.2 United States Peptide Therapeutics Sales Growth Rate by Application (2012-2017)
  • 5.3 Market Drivers and Opportunities
  • 6 United States Peptide Therapeutics Players/Suppliers Profiles and Sales Data
  • 6.1 Pfizer
  • 6.1.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.1.2 Peptide Therapeutics Product Category, Application and Specification
  • 6.1.2.1 Product A
  • 6.1.2.2 Product B
  • 6.1.3 Pfizer Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.1.4 Main Business/Business Overview
  • 6.2 Eli Lilly and Company
  • 6.2.2 Peptide Therapeutics Product Category, Application and Specification
  • 6.2.2.1 Product A
  • 6.2.2.2 Product B
  • 6.2.3 Eli Lilly and Company Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.2.4 Main Business/Business Overview
  • 6.3 Bachem Holding
  • 6.3.2 Peptide Therapeutics Product Category, Application and Specification
  • 6.3.2.1 Product A
  • 6.3.2.2 Product B
  • 6.3.3 Bachem Holding Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.3.4 Main Business/Business Overview
  • 6.4 Amgen
  • 6.4.2 Peptide Therapeutics Product Category, Application and Specification
  • 6.4.2.1 Product A
  • 6.4.2.2 Product B
  • 6.4.3 Amgen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.4.4 Main Business/Business Overview
  • 6.5 Roche
  • 6.5.2 Peptide Therapeutics Product Category, Application and Specification
  • 6.5.2.1 Product A
  • 6.5.2.2 Product B
  • 6.5.3 Roche Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.5.4 Main Business/Business Overview
  • 6.6 GlaxoSmithKline
  • 6.6.2 Peptide Therapeutics Product Category, Application and Specification
  • 6.6.2.1 Product A
  • 6.6.2.2 Product B
  • 6.6.3 GlaxoSmithKline Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.6.4 Main Business/Business Overview
  • 6.7 Novartis
  • 6.7.2 Peptide Therapeutics Product Category, Application and Specification
  • 6.7.2.1 Product A
  • 6.7.2.2 Product B
  • 6.7.3 Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.7.4 Main Business/Business Overview
  • 6.8 Sanofi
  • 6.8.2 Peptide Therapeutics Product Category, Application and Specification
  • 6.8.2.1 Product A
  • 6.8.2.2 Product B
  • 6.8.3 Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.8.4 Main Business/Business Overview
  • 6.9 Takeda Pharmaceutical Company
  • 6.9.2 Peptide Therapeutics Product Category, Application and Specification
  • 6.9.2.1 Product A
  • 6.9.2.2 Product B
  • 6.9.3 Takeda Pharmaceutical Company Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.9.4 Main Business/Business Overview
  • 6.10 Teva Pharmaceutical
  • 6.10.2 Peptide Therapeutics Product Category, Application and Specification
  • 6.10.2.1 Product A
  • 6.10.2.2 Product B
  • 6.10.3 Teva Pharmaceutical Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  • 6.10.4 Main Business/Business Overview
  • 7 Peptide Therapeutics Manufacturing Cost Analysis
  • 7.1 Peptide Therapeutics Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Price Trend of Key Raw Materials
  • 7.1.3 Key Suppliers of Raw Materials
  • 7.1.4 Market Concentration Rate of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.2.1 Raw Materials
  • 7.2.2 Labor Cost
  • 7.2.3 Manufacturing Expenses
  • 7.3 Manufacturing Process Analysis of Peptide Therapeutics
  • 8 Industrial Chain, Sourcing Strategy and Downstream Buyers
  • 8.1 Peptide Therapeutics Industrial Chain Analysis
  • 8.2 Upstream Raw Materials Sourcing
  • 8.3 Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2016
  • 8.4 Downstream Buyers
  • 9 Marketing Strategy Analysis, Distributors/Traders
  • 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
  • 9.1.3 Marketing Channel Development Trend
  • 9.2 Market Positioning
  • 9.2.1 Pricing Strategy
  • 9.2.2 Brand Strategy
  • 9.2.3 Target Client
  • 9.3 Distributors/Traders List
  • 10 Market Effect Factors Analysis
  • 10.1 Technology Progress/Risk
  • 10.1.1 Substitutes Threat
  • 10.1.2 Technology Progress in Related Industry
  • 10.2 Consumer Needs/Customer Preference Change
  • 10.3 Economic/Political Environmental Change
  • 11 United States Peptide Therapeutics Market Size (Value and Volume) Forecast (2017-2022)
  • 11.1 United States Peptide Therapeutics Sales Volume, Revenue Forecast (2017-2022)
  • 11.2 United States Peptide Therapeutics Sales Volume Forecast by Type (2017-2022)
  • 11.3 United States Peptide Therapeutics Sales Volume Forecast by Application (2017-2022)
  • 11.4 United States Peptide Therapeutics Sales Volume Forecast by Region (2017-2022)
  • 12 Research Findings and Conclusion
  • 13 Appendix
  • 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
  • 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
  • 13.3 Disclaimer

Please select a license type

Share

Related Products

QYResearchUnited States Peptide Therapeutics Market Report 2017 Product ThumbnailUnited States Peptide Therapeutics Market Report 2017 , Industry ReportProduct #: 871221
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved